Zoetis
Zoetis develops and manufactures animal-health medicines and vaccines whose customers include veterinarians, pet owners, and livestock farmers.
Sipa via AP Images
Company Information
As of 10/10/2022
Country
U.S.
Headquarters
Parsippany, N.J.
Industry
Pharmaceuticals
CEO
Kristin Peck
Website
Company Type
Public
Ticker
ZTS
Revenues ($M)
$7,776
Profits ($M)
$2,035
Market Value ($M)
$69,420
Employees
12,100
Market value as of Sept. 30, 2022.
Change the World
Impact Segment
Environmental Impact/Economic Opportunity
Sector
Health Care
Prior Year Rank
-
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
-
-
Profits ($M)
-
-
Assets ($M)
-
-
Total Stockholder Equity ($M)
-
-
Profit Ratios
Profit as % of Revenues
-
Profits as % of Assets
-
Profits as % of Stockholder Equity
-
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
-
EPS % Change (from 2020)
-
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2021)
-
Total Return to Investors (5 year, annualized)
-
Total Return to Investors (10 year, annualized)
-
Lists ranking Zoetis
Latest news for Zoetis
- Leadership
Zoetis CEO on equalizing the work experience for in-office and remote employeesSeptember 21, 2022, 10:00 PM UTC - Newsletters
How Zoetis’s CEO is catering to the hands-on millennial pet ownerAugust 30, 2022, 12:16 PM UTC - Leadership
Empathy is the go-to leadership skill of the moment—and yes, it can be learnedNovember 10, 2021, 10:00 AM UTC